Life Science Compliance Update



Has the Shine Worn Off False Claims QUI TAM Actions

Written by , Posted in Uncategorized

Gwendolyn Ball, Staff Writer, Life Science Compliance Update

At the recent HCCA Annual Conference, the Deputy Director of DOJ’s Civil Fraud Section may have signaled a change in policy relative to handling qui tam cases. This article explores the issue and what it might mean for life science companies going forward.


Topic tags:

Menu Title